A Randomized Controlled Trial of Fasting and Lifestyle Modification in Patients with Metabolic Syndrome: Effects on Patient-Reported Outcomes

Nutrients. 2022 Aug 29;14(17):3559. doi: 10.3390/nu14173559.

Abstract

Lifestyle interventions can have a positive impact on quality of life and psychological parameters in patients with metabolic syndrome (MetS). In this randomized controlled trial, 145 participants with MetS (62.8% women; 59.7 ± 9.3 years) were randomized to (1) 5-day fasting followed by 10 weeks of lifestyle modification (F + LM; modified DASH diet, exercise, mindfulness; n = 73) or (2) 10 weeks of lifestyle modification only (LM; n = 72). Outcomes were assessed at weeks 0, 1, 12, and 24, and included quality of life (Short-Form 36 Health Survey Questionnaire, SF-36), anxiety/depression (Hospital Anxiety and Depression Scale, HADS), stress (Cohen Perceived Stress Scale, CPSS), mood (Profile of Mood States, POMS), self-efficacy (General Self-Efficacy Scale, GSE), mindfulness (Mindfulness Attention Awareness Scale, MAAS), and self-compassion (Self-Compassion Scale, SCS). At week 1, POMS depression and fatigue scores were significantly lower in F + LM compared to LM. At week 12, most self-report outcomes improved in both groups-only POMS vigor was significantly higher in F + LM than in LM. Most of the beneficial effects within the groups persisted at week 24. Fasting can induce mood-modulating effects in the short term. LM induced several positive effects on quality of life and psychological parameters in patients with MetS.

Keywords: MICOM (Mind-Body Medicine in Integrative and Complementary Medicine); Mediterranean diet; fasting; lifestyle; metabolic syndrome; mindfulness; modified DASH diet; relaxation; self-efficacy.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Depression / psychology
  • Depression / therapy
  • Fasting
  • Female
  • Humans
  • Life Style
  • Male
  • Metabolic Syndrome* / therapy
  • Patient Reported Outcome Measures
  • Quality of Life* / psychology